DWS ESG Biotech LC Fonds
296,42
EUR
+1,70
EUR
+0,58
%
295,19
EUR
+2,44
EUR
+0,83
%
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 9,08% |
| Amgen Inc | US0311621009 | 8,16% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 7,71% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,34% |
| argenx SE | NL0010832176 | 4,25% |
| Gilead Sciences Inc | US3755581036 | 3,20% |
| Blueprint Medicines Corp | US09627Y1091 | 3,18% |
| Sarepta Therapeutics Inc | US8036071004 | 3,17% |
| Intra-Cellular Therapies Inc | US46116X1019 | 3,08% |
| Ultragenyx Pharmaceutical Inc | US90400D1081 | 3,04% |
| Sonstige | 50,78% |